Relationship between serum aminotransferase levels andmetabolic disorders in Northern China

Iranian Journal of Public Health

Volumn 41, Issue 2, 2012, Pages 15-26

  Zhang, H ^a   Ding, Yh ^a   Li, Qm ^a   Sun, J ^a   He, Sm ^a   Feng, Xw ^a   Zhao, Yl ^a   Zhou, Xj ^a   Cai, Yj ^a   Wang, C ^a   Shi, Xd ^a   Wang, Zf ^a   Zhou, Q ^a   Niu, Jq ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Alanine aminotransferase; Cutoff levels; Metabolic syndrome; Non alcoholic fatty liver disease; Ultrasonography

Indexed keywords

EID: 84875309393     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Luyckx FH, Lefebvre PJ, Scheen AJ (2000). Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab, 26: 98-106.
2. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. (2003). Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology, 37: 917-23.
3. Xanthakos S, Miles L, Bucuvalas J, Daniels S, Garcia V, Inge T (2006). Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents. Clin Gastroenterol Hepatol, 4: 226-32.
4. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, et al. (2007). Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol, 22: 1482-9.
5. Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP (2007). Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol, 102: 399-408.
6. Choi SY KD, Kang JH, Park MJ, Lee HS (2008). Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis. Korean J Hepatol, 14: 77-88.
7. Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, et al. (2008). Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology, 48: 792-8.
8. Zhu LY HL, Li XL, Wang GY, Shan W, Ma LC, Wang XH (2010). Relationship between Trp64Arg mutation in the β3- adrenergic receptor gene and metabolic syndrome: a seven-year follow-up study. Chin Med J (Engl), 123: 2375-8.
9. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, et al. (1999). Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab, 84: 1513-7.
10. Pagano G PG, Musso G, Gambino R, Mecca F, Depetris N (2002). Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology, 35: 367-72.
11. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Maccioni D, et al. (2003). Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol, 18: 588-94.
12. Tian JL, Zhang Y, Chen BY (2010). Sleep apnea hypopnea syndrome and liver injury. Chin Med J (Engl),123: 89-94.
13. Kelishadi R CS, Amra B, Adibi A (2009). Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths. Atherosclerosis, 204: 538-43.
14. Oh SY CY, Kang MS, Yoo TW, Park JH (2006). The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism, 55:1604-9.
15. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I (2004). Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ, 328: 983.
16. Liu M, Yan HM, Gao X, Gao J (2007). [Association of abnormality of liver enzymes and metabolic syndrome in patients with nonalcoholic fatty liver disease]. Zhonghua Yi Xue Za Zhi, 87: 253-5.
17. Sanyal AJ (2002). AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. Gastroenterology, 123: 1705-25.
18. Alberti KG, Zimmet P, Shaw J (2006). Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, 23: 469-80.
19. Liangpunsakul S, Chalasani N (2005). Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III). Am J Med Sci, 329: 111-6.
20. Finelli C CP, Contaldo F, Pasanisi F (2005). Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy. Ann Nutr Metab, 49: 289-95.
21. Saito T, Nishise Y, Makino N, Haga H, Ishii R, Okumoto K, et al. (2009). Impact of metabolic syndrome on elevated serum alanine aminotransferase levels in the Japanese population. Metabolism, 58: 1067-75.
22. Kim HC, Choi KS, Jang YH, Shin HW, Kim DJ (2006). Normal serum aminotransferase levels and the metabolic syndrome: Korean National Health and Nutrition Examination Surveys. Yonsei Med J, 47: 542-50.
23. Nah EH, Park JY (2008). Metabolic characteristics and associated factors of nonalcoholic fatty liver disease diagnosed at medical checkups. Korean J Lab Med, 28: 244-50.
24. Omagari KKY, Masuda J, Egawa I, Sawa T, Hazama H (2002). Fatty liver in nonalcoholic non-overweight Japanase adults: incidence and clinical characteristics. J Gastroenterol Hepatol, 17: 1098-105.
25. Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, et al. (2002). Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes, 51: 2951-8.
26. Deurenberg P D-YM, Guricci S (2002). Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev, 3: 141-6.
27. Mathiesen UL, Franzen LE, Fryden A, Foberg U, Bodemar G (1999). The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. Scand J Gastroenterol, 34: 85-91.
28. Lee JK, Shim JH, Lee HC, Lee SH, Kim KM, Lim YS, et al. (2010). Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology. Hepatology, 51: 1577-83.